Yves Leestemaker

746 total citations
7 papers, 498 citations indexed

About

Yves Leestemaker is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Yves Leestemaker has authored 7 papers receiving a total of 498 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 2 papers in Oncology and 1 paper in Surgery. Recurrent topics in Yves Leestemaker's work include Ubiquitin and proteasome pathways (6 papers), Protein Degradation and Inhibitors (4 papers) and Peptidase Inhibition and Analysis (2 papers). Yves Leestemaker is often cited by papers focused on Ubiquitin and proteasome pathways (6 papers), Protein Degradation and Inhibitors (4 papers) and Peptidase Inhibition and Analysis (2 papers). Yves Leestemaker collaborates with scholars based in Netherlands, United States and Germany. Yves Leestemaker's co-authors include Huib Ovaa, Kevin D. Rynearson, Martin Giera, Lauren Fong, Rik van der Kant, Lawrence S.B. Goldstein, Steven L. Wagner, Vanessa F. Langness, Anne G. Bang and J. Bernd Helms and has published in prestigious journals such as The Journal of Immunology, Cell stem cell and Molecular Pharmaceutics.

In The Last Decade

Yves Leestemaker

7 papers receiving 491 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yves Leestemaker Netherlands	6	348	131	74	72	65	7	498
Chandresh R. Gajera United States	9	266 0.8×	122 0.9×	54 0.7×	70 1.0×	36 0.6×	18	525
Kang‐Sik Park South Korea	12	334 1.0×	64 0.5×	59 0.8×	95 1.3×	46 0.7×	19	607
Emilie Schrepfer Italy	7	456 1.3×	105 0.8×	141 1.9×	54 0.8×	49 0.8×	7	633
Mahaboobi Jaleel Finland	10	570 1.6×	170 1.3×	92 1.2×	158 2.2×	59 0.9×	20	896
Roxana Samimi United States	5	179 0.5×	75 0.6×	49 0.7×	50 0.7×	59 0.9×	6	368
Steven Huyghe Belgium	11	537 1.5×	152 1.2×	36 0.5×	44 0.6×	66 1.0×	17	666
Michelle Connell United Kingdom	8	355 1.0×	125 1.0×	36 0.5×	78 1.1×	55 0.8×	13	618
Femke M. Feringa Netherlands	8	320 0.9×	147 1.1×	20 0.3×	61 0.8×	96 1.5×	14	508
Connor S.R. Jankowski United States	12	528 1.5×	113 0.9×	62 0.8×	50 0.7×	27 0.4×	16	722
Neelanjan Vishnu Sweden	15	487 1.4×	158 1.2×	71 1.0×	89 1.2×	30 0.5×	17	747

Countries citing papers authored by Yves Leestemaker

Since Specialization

Citations

This map shows the geographic impact of Yves Leestemaker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yves Leestemaker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yves Leestemaker more than expected).

Fields of papers citing papers by Yves Leestemaker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yves Leestemaker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yves Leestemaker. The network helps show where Yves Leestemaker may publish in the future.

Co-authorship network of co-authors of Yves Leestemaker

This figure shows the co-authorship network connecting the top 25 collaborators of Yves Leestemaker. A scholar is included among the top collaborators of Yves Leestemaker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yves Leestemaker. Yves Leestemaker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Jin, Gan, Yves Leestemaker, Ayşegül Sapmaz, & Huib Ovaa. (2019). Highlighting the Proteasome: Using Fluorescence to Visualize Proteasome Activity and Distribution. Frontiers in Molecular Biosciences. 6. 14–14. 30 indexed citations

2.

Kant, Rik van der, Vanessa F. Langness, Cheryl Herrera, et al.. (2019). Cholesterol Metabolism Is a Druggable Axis that Independently Regulates Tau and Amyloid-β in iPSC-Derived Alzheimer’s Disease Neurons. Cell stem cell. 24(3). 363–375.e9. 231 indexed citations

3.

Jong, Annemieke de, Yves Leestemaker, Paul P. Geurink, et al.. (2017). Inhibition of the Deubiquitinase Usp14 Diminishes Direct MHC Class I Antigen Presentation. The Journal of Immunology. 200(3). 928–936. 13 indexed citations

4.

Leestemaker, Yves & Huib Ovaa. (2017). Tools to investigate the ubiquitin proteasome system. Drug Discovery Today Technologies. 26. 25–31. 66 indexed citations

5.

Leestemaker, Yves, Annemieke de Jong, Katharina F. Witting, et al.. (2017). Proteasome Activation by Small Molecules. Cell chemical biology. 24(6). 725–736.e7. 117 indexed citations

6.

Leestemaker, Yves, Annemieke de Jong, & Huib Ovaa. (2016). Profiling the Activity of Deubiquitinating Enzymes Using Chemically Synthesized Ubiquitin-Based Probes. Methods in molecular biology. 1491. 113–130. 4 indexed citations

7.

Berkers, Celia R., Yves Leestemaker, Karianne Schuurman, et al.. (2012). Probing the Specificity and Activity Profiles of the Proteasome Inhibitors Bortezomib and Delanzomib. Molecular Pharmaceutics. 9(5). 1126–1135. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact